BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24705308)

  • 1. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
    Andrews C; Humphrey PA
    Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
    Warrick JI; Humphrey PA
    Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
    Hameed O; Sublett J; Humphrey PA
    Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
    Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI
    Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
    Zhou M; Jiang Z; Epstein JI
    Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
    Adley BP; Yang XJ
    Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
    Farinola MA; Epstein JI
    Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
    Zhou M; Aydin H; Kanane H; Epstein JI
    Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
    Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
    Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.
    Jiang Z; Wu CL; Woda BA; Dresser K; Xu J; Fanger GR; Yang XJ
    Am J Surg Pathol; 2002 Sep; 26(9):1169-74. PubMed ID: 12218573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
    Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
    Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
    Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
    Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
    Shah RB; Tadros Y; Brummell B; Zhou M
    Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
    Jiang Z; Li C; Fischer A; Dresser K; Woda BA
    Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.
    Vanguri VK; Woda BA; Jiang Z
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):365-8. PubMed ID: 16932031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of ERG in Prostate Needle Biopsies Containing Minute Cancer Foci.
    Bachurska SY; Staykov DG; Bakardzhiev IV; Antonov PA; Belovezhdov VT
    Folia Med (Plovdiv); 2017 Mar; 59(1):84-90. PubMed ID: 28384107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
    Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
    Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
    Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.